Observational studyBMC geriatrics2026
The mediating role of acute postoperative pain in the relationship between intraoperative dexmedetomidine and neuropsychiatric outcomes following gastrointestinal surgery in elderly patients: a multicenter observational study.
Observational study in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe relationships among intraoperative dexmedetomidine administration, acute postoperative pain, and postoperative neuropsychiatric complications in elderly patients receiving gastrointestinal surgery remain incompletely characterized.
methodsThis multicenter cohort study analyzed data from the Perioperative Database of Chinese Elderly Patients. The participants who underwent gastrointestinal surgery were divided into two groups: the dexmedetomidine group and the nondexmedetomidine group. The primary outcome was 30-day postoperative neuropsychiatric complications, whereas secondary outcomes included severe pain, surgery-related, respiratory, cardiovascular, and digestive system complications, and acute kidney injury. Propensity score matching balanced the baseline characteristics. Associations between dexmedetomidine and outcomes were assessed via univariate and multivariate logistic regression. Subgroup analyses and mediation analysis were used to evaluate the correlations and relationships among dexmedetomidine, postoperative pain, and neuropsychiatric complications. Multivariate regression was used to examine the dose‒response effects of dexmedetomidine.
resultsOf the 1388 eligible patients, 333 (24.0%) received intraoperative dexmedetomidine at a median dose of 30 μg (interquartile range [IQR]: 20–72 μg) or 0.5 μg/kg (IQR: 0.4–1.1 μg/kg). The dexmedetomidine group had significantly lower rates of neuropsychiatric complications (17.4% vs. 23.5%), surgery-related complications (7.8% vs. 13.7%), and digestive system complications (0.3% vs. 2.9%). Multivariate analysis indicated that dexmedetomidine was associated with reduced neuropsychiatric complications (OR: 0.641; 95% CI: 0.454 to 0.906, P = 0.012) and severe postoperative pain (OR: 0.591; 95% CI: 0.433 to 0.808, P = 0.001). Mediation analysis revealed an indirect effect through acute pain reduction (aOR -0.059, 95% CI -0.109 to -0.014, P=0.004), accounting for 13.0% of the total effect.
conclusionIntraoperative dexmedetomidine was significantly associated with reduced postoperative neuropsychiatric complications in elderly gastrointestinal surgery patients. The reduction in severe pain may partially mediate the relationship between dexmedetomidine use and the lower incidence of neuropsychiatric complications. These findings suggest an association rather than proving causation and must be validated through randomized controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.